Please select your page

Press Releases

Please find below a list of all Knight press releases:

January 26, 2017

Knight Plants Small Seed Position In Protalix

January 13, 2017

Knight Disposes of Shares of Pediapharm Inc.

January 9, 2017

API Is Core to Knight’s Successful Investment

December 28, 2016

Knight Creates Many GUD Synergies with its Partner

December 22, 2016

Knight Therapeutics Completes Previously Announced Bought Deal of Common Shares, Including Exercise of Over-Allotment Option, for $100 million

December 19, 2016

Knight Adds New Dimension to 3D Signatures Partnership

December 15, 2016

Knight Therapeutics Announces Exclusive License Agreement with AstraZeneca for Movantik/Moventig® in Canada and Israel

December 6, 2016

 Knight Therapeutics Announces Increase to Bought Deal Financing

December 6, 2016

 Knight Therapeutics Enters into Agreement for a $75 Million Bought Deal of Common Shares

November 10, 2016

 Knight Reports Third Quarter 2016 Results

September 19, 2016

 Knight to Present at the 15th Annual CIBC Eastern Institutional Investor Conference in Montreal

September 9, 2016

Ink Dry on 3D Signatures Partnership with Knight

September 1, 2016

INTEGA Skin Primed for Crescita (Italian for Growth)

August 17, 2016

A Knight is Reborn

August 16, 2016

In the Beginning of a Genesys Partnership

August 15, 2016

Knight Medison Relationship Continues to Pay Dividends

August 12, 2016

Knight Lends a Second Hand to Bloom Burton Debt Fund

August 11, 2016

Knight Reports Second Quarter 2016 Results

August 2, 2016

SIFI S.p.A. and Knight Therapeutics Announce Canadian License Agreement for NETILDEX™

July 15, 2016

Knight Acquires Minor Stake in Pediapharm

July 6, 2016

Knight and Ember Expand Distribution Partnership

June 16, 2016

Knight Therapeutics Inc. announces election of directors

June 2, 2016

Knight Therapeutics Completes Previously Announced Bought Deal of Common Shares, Including Exercise of Over-Allotment Option, for $230 million

May 31, 2016

Knight to Present at both the National Bank Financial Quebec Conference in Montreal and the Jefferies Healthcare Conference in New York City

May 11, 2016

Knight Therapeutics Enters into Agreement for a $200 Million Bought Deal of Common Shares

May 10, 2016

Knight Reports First Quarter 2016 Results

April 25, 2016

Knight Blooms at Healthcare Investor Conference in Toronto

April 25, 2016

Knight Receives NOD from Health Canada for ATryn®

April 25, 2016

Knight Finds EMPAthetic Partner for Neuragen® in the Middle East

March 24, 2016

Knight Reports Fourth Quarter and Year-Ended December 31, 2015 Results

March 23, 2016

Knight Receives Dividend from Medison

March 22, 2016

Knight Partner Profounda Inc. Launches Impavido in U.S.

March 15, 2016

Knight Obtains Impavido Worldwide Rights

February 17, 2016

Knight Breaks Glass on Medimetriks Partnership

Knight Medimetriks Transaction Overview Print / View PDF

February 1, 2016

Braeburn Pharmaceuticals and Knight Therapeutics Announce Canadian Sublicense Agreement for PROBUPHINE®

January 25, 2016

INTEGA Skin Looks GUD to Knight

Buy now

You can now buy this awesome Joomla Theme directly on Themeforest for a really low price for this awesome and stunning Joomla product!

Nulla vitae elit libero, a pharetra augue. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam porta sem malesuada magna mollis euismod. Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Nulla vitae elit libero, a pharetra augue.

BUY NOW ON THEMEFOREST

×

Login

Please login using your credentials recived by email when you register.

  or   Create an account

Forgot your password? |  Forgot your username?

×

Register now


I'm a small Introtext for the Register Module, I can be set in the Backend of the Joomla WS-Register Module.



  or   Login
×